The Thrombopoietin Receptor Agonist Lusutrombopag Is Effective for Patients with Chronic Liver Disease and Impaired Renal Function.
| Autor: | Hirohito Takeuchi1, Yoshihiro Furuichi1,2 furuich@tokyo-med.ac.jp, Yu Yoshimasu1, Yoshitaka Kasai1, Masakazu Abe1, Katsutoshi Sugimoto1, Takao Itoi1 |
|---|---|
| Zdroj: | Journal of Nippon Medical School. 2020, Vol. 87 Issue 6, p325-333. 9p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|